Literature DB >> 17572682

A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription.

Yufeng Wei1, Shaohua Liu, Jörn Lausen, Christopher Woodrell, Seongeun Cho, Nikolaos Biris, Naohiro Kobayashi, Yu Wei, Shigeyuki Yokoyama, Milton H Werner.   

Abstract

The eight twenty-one protein, ETO, is implicated in 12%-15% of acute human leukemias as part of a gene fusion with RUNX1 (also called AML1). Of the four ETO domains related to Drosophila melanogaster Nervy, only two are required to induce spontaneous myeloid leukemia upon transplantation into the mouse. One of these domains is related in sequence to TAF4, a component of TFIID. The structure of this domain, ETO-TAFH, is similar to yeast Rpb4 and to Escherichia coli sigma(70); it is the first TAF-related protein with structural similarity to the multisubunit RNA polymerases. Overlapping surfaces of ETO-TAFH interact with an autonomous repression domain of the nuclear receptor corepressor N-CoR and with a conserved activation domain from the E-box family of transcription factors. Thus, ETO-TAFH acts as a structural platform that can interchange negative and positive coregulatory proteins to control transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572682     DOI: 10.1038/nsmb1258

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  25 in total

1.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

2.  Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.

Authors:  Sangho Park; Wei Chen; Tomasz Cierpicki; Marco Tonelli; Xiongwei Cai; Nancy A Speck; John H Bushweller
Journal:  Blood       Date:  2009-02-09       Impact factor: 22.113

3.  Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.

Authors:  Chun Guo; Qiande Hu; Chunxia Yan; Jinsong Zhang
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

4.  Chaperonin TRiC/CCT Recognizes Fusion Oncoprotein AML1-ETO through Subunit-Specific Interactions.

Authors:  Soung-Hun Roh; Moses M Kasembeli; Jesús G Galaz-Montoya; Wah Chiu; David J Tweardy
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  ZFP628 Is a TAF4b-Interacting Transcription Factor Required for Mouse Spermiogenesis.

Authors:  Eric A Gustafson; Kimberly A Seymour; Kirsten Sigrist; Dirk G D E Rooij; Richard N Freiman
Journal:  Mol Cell Biol       Date:  2020-03-16       Impact factor: 4.272

Review 6.  RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

Authors:  James K Mangan; Nancy A Speck
Journal:  Crit Rev Oncog       Date:  2011

7.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

8.  The RST and PARP-like domain containing SRO protein family: analysis of protein structure, function and conservation in land plants.

Authors:  Pinja Jaspers; Kirk Overmyer; Michael Wrzaczek; Julia P Vainonen; Tiina Blomster; Jarkko Salojärvi; Ramesha A Reddy; Jaakko Kangasjärvi
Journal:  BMC Genomics       Date:  2010-03-12       Impact factor: 3.969

9.  Feedback regulation of NEUROG2 activity by MTGR1 is required for progression of neurogenesis.

Authors:  Joshua D Aaker; Andrea L Patineau; Hyun-Jin Yang; David T Ewart; Wuming Gong; Tongbin Li; Yasushi Nakagawa; Steven C McLoon; Naoko Koyano-Nakagawa
Journal:  Mol Cell Neurosci       Date:  2009-07-28       Impact factor: 4.314

10.  Transforming activity of AML1-ETO is independent of CBFbeta and ETO interaction but requires formation of homo-oligomeric complexes.

Authors:  Colin Kwok; Bernd B Zeisig; Jihui Qiu; Shuo Dong; Chi Wai Eric So
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.